Was one of first retinal specialists to use Lucentis for Exudative Macular Degeneration in S.E.Chief Resident Charles Drew University/UCLA 2004.Pacific American Volunteer Association Appreciation Award 20.Interests include Epiretinal membranes, Macular holes, Pneumatic retinopexy for treatment of retinal detachments.Sci., King/Drew Medical Center, Los Angeles, CA “Epidemiology of Patients with Endophthalmitis Admitted to California Hospitals between 19.” Ophthalmology Vis.“New Concepts in the Management of Retinopathy of Prematurity” Speaker, Medical University of South Carolina, 2005 Abstracts published in 2003 “Age Related Macular Degeneration and Retinitis Pigmentosa in an Hispanic Family.”.Co-investigator with Allergan Posurdex Phase 3 retinal Vein Occlusion Program, University of VA, 2005.Consultant for OSI/Eyetech – Age Related Macular Degeneration, Boston, MA, 2007 – Present.Consultant for Genentech-Lucentis case studies, Boston, MA, 2009.Research, Publications and Areas of Interest
0 kommentar(er)
